25295 Mrv0541 02241214202D 20 21 0 0 1 0 999 V2000 2.3645 -3.0938 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 0.6188 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 0.2063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.8563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 -1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 3.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 18 1 0 0 0 0 2 5 1 0 0 0 0 2 7 1 0 0 0 0 2 8 1 0 0 0 0 3 6 1 0 0 0 0 3 10 1 0 0 0 0 3 11 1 0 0 0 0 4 8 1 0 0 0 0 4 19 2 0 0 0 0 5 6 1 0 0 0 0 7 9 1 0 0 0 0 8 14 2 0 0 0 0 9 12 2 0 0 0 0 9 13 1 0 0 0 0 12 15 1 0 0 0 0 13 16 2 0 0 0 0 14 17 1 0 0 0 0 15 18 2 0 0 0 0 16 18 1 0 0 0 0 17 20 2 0 0 0 0 19 20 1 0 0 0 0 M END > DB08800 > drugbank > CN(C)CCN(CC1=CC=C(Cl)C=C1)C1=CC=CC=N1 > InChI=1S/C16H20ClN3/c1-19(2)11-12-20(16-5-3-4-10-18-16)13-14-6-8-15(17)9-7-14/h3-10H,11-13H2,1-2H3 > ICKFFNBDFNZJSX-UHFFFAOYSA-N > C16H20ClN3 > 289.803 > 289.134575362 > 3 > 40 > 1.00331634354511 > 32.25395283921345 > 1 > 0 > 0 > 1 > N-[(4-chlorophenyl)methyl]-N-[2-(dimethylamino)ethyl]pyridin-2-amine > 3.79 > 3.8052370936666664 > -2.82 > 0 > 1 > 2 > 1 > 8.763974494958228 > 19.37 > 86.07970000000002 > 6 > 1 > 4.41e-01 g/l > tetrahydrofolic acid > 1 > DB08800 > DB07523 > experimental > Chloropyramine > Chloropyramine; Chloropyraminum; Chlorpyramine; Cloropiramina; Halopyramine > Avapena; Suprastin; Synopen > Chloropyramine hydrochloride $$$$